Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

(-)-Cotinine

(-)-Cotinine

486-56-6

DISCOVER
CLOTRIMAZOLE CRS (100 MG)

CLOTRIMAZOLE CRS (100 MG)

23593-75-1

DISCOVER
CLOXACILLIN SODIUM CRS (230 MG)

CLOXACILLIN SODIUM CRS (230 MG)

7081-44-9

DISCOVER
CLOZAPINE CRS (60 MG)

CLOZAPINE CRS (60 MG)

5786-21-0

DISCOVER
COCOYL CAPRYLOCAPRATE  CRS (40 MG)

COCOYL CAPRYLOCAPRATE CRS (40 MG)

NA

DISCOVER
Codeine - reference spectrum,Qty : n/a

Codeine - reference spectrum,Qty : n/a

NA

DISCOVER
Codeine hydrochloride dihydrate - reference spectrum, Qty :n/a

Codeine hydrochloride dihydrate - reference spectrum, Qty :n/a

NA

DISCOVER
CODERGOCRINE MESILATE CRS (60MG)

CODERGOCRINE MESILATE CRS (60MG)

8067-24-1

DISCOVER
Chlorhexidine 2HCl

Chlorhexidine 2HCl

3697-42-5

DISCOVER
COLCHICINE CRS (15 MG)

COLCHICINE CRS (15 MG)

64-86-8

DISCOVER
Cholesterol

Cholesterol

57-88-5

DISCOVER
COLISTIMETHATE SODIUM CRS (26.212 MG)

COLISTIMETHATE SODIUM CRS (26.212 MG)

8068-28-8

DISCOVER